Pricing
Login
Home
Charts
Search
Watchlist
Products

Glaxosmithkline Pharmaceuticals Ltd

GLAXO
₹2,727.60+0.52%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Glaxosmithkline Pharmaceuticals Ltd

GLAXO
₹2,727.60
+0.52%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹46,207Cr
Close
Close Price
₹2,727.60
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
40.85
PS
Price To Sales
11.11
Revenue
Revenue
₹4,159Cr
Rev Gr TTM
Revenue Growth TTM
12.12%
PAT Gr TTM
PAT Growth TTM
20.03%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8059308151,0119499748059801,0419959381,184
Growth YoY
Revenue Growth YoY%
0.418.17.05.617.94.8-1.2-3.09.72.116.620.8
Expenses
ExpensesCr
587673584689658641554644670644643782
Operating Profit
Operating ProfitCr
218257231322292333251336371351296402
OPM
OPM%
27.127.728.331.830.834.231.234.335.735.331.534.0
Other Income
Other IncomeCr
-1353236393541443650364473
Interest Expense
Interest ExpenseCr
010001011110
Depreciation
DepreciationCr
171816171915161720131615
PBT
PBTCr
65271249344308359279354400373322459
Tax
TaxCr
20766791789674971049585123
PAT
PATCr
46194182253230263205257296278237336
Growth YoY
PAT Growth YoY%
-72.245.837.916.1402.835.212.42.028.65.715.730.4
NPM
NPM%
5.720.922.425.024.227.025.526.328.427.925.328.4
EPS
EPS₹
9.911.410.814.713.615.512.115.116.516.414.019.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8059308151,0119499748059801,0419959381,184
Growth YoY
Revenue Growth YoY%
0.418.17.05.617.94.8-1.2-3.09.72.116.620.8
Expenses
ExpensesCr
587673584689658641554644670644643782
Operating Profit
Operating ProfitCr
218257231322292333251336371351296402
OPM
OPM%
27.127.728.331.830.834.231.234.335.735.331.534.0
Other Income
Other IncomeCr
-1353236393541443650364473
Interest Expense
Interest ExpenseCr
010001011110
Depreciation
DepreciationCr
171816171915161720131615
PBT
PBTCr
65271249344308359279354400373322459
Tax
TaxCr
20766791789674971049585123
PAT
PATCr
46194182253230263205257296278237336
Growth YoY
PAT Growth YoY%
-72.245.837.916.1402.835.212.42.028.65.715.730.4
NPM
NPM%
5.720.922.425.024.227.025.526.328.427.925.328.4
EPS
EPS₹
9.911.410.814.713.615.512.115.116.516.414.019.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,8382,9082,8713,1283,2242,9263,2783,2523,4543,7493,8224,159
Growth
Revenue Growth%
-14.12.5-1.38.93.1-9.312.1-0.86.28.61.912.1
Expenses
ExpensesCr
2,3602,4892,3662,5272,5672,3272,5162,4472,5452,5722,5122,739
Operating Profit
Operating ProfitCr
4784195066016575987628049091,1771,3091,420
OPM
OPM%
16.914.417.619.220.420.423.224.726.331.434.334.1
Other Income
Other IncomeCr
12511972131-262-6287100-21151166203
Interest Expense
Interest ExpenseCr
000164222133
Depreciation
DepreciationCr
252638498379686670676664
PBT
PBTCr
5785115406833064547798368161,2601,4061,555
Tax
TaxCr
202174189237213167398229226332370408
PAT
PATCr
376337351445932873816085909281,0361,147
Growth
PAT Growth%
-21.1-10.54.127.0-79.1208.232.559.6-2.957.211.720.0
NPM
NPM%
13.311.612.214.22.99.811.618.717.124.727.127.6
EPS
EPS₹
22.219.920.726.35.521.1100.036.141.154.560.166.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,8382,9082,8713,1283,2242,9263,2783,2523,4543,7493,8224,159
Growth
Revenue Growth%
-14.12.5-1.38.93.1-9.312.1-0.86.28.61.912.1
Expenses
ExpensesCr
2,3602,4892,3662,5272,5672,3272,5162,4472,5452,5722,5122,739
Operating Profit
Operating ProfitCr
4784195066016575987628049091,1771,3091,420
OPM
OPM%
16.914.417.619.220.420.423.224.726.331.434.334.1
Other Income
Other IncomeCr
12511972131-262-6287100-21151166203
Interest Expense
Interest ExpenseCr
000164222133
Depreciation
DepreciationCr
252638498379686670676664
PBT
PBTCr
5785115406833064547798368161,2601,4061,555
Tax
TaxCr
202174189237213167398229226332370408
PAT
PATCr
376337351445932873816085909281,0361,147
Growth
PAT Growth%
-21.1-10.54.127.0-79.1208.232.559.6-2.957.211.720.0
NPM
NPM%
13.311.612.214.22.99.811.618.717.124.727.127.6
EPS
EPS₹
22.219.920.726.35.521.1100.036.141.154.560.166.8
Sales CAGR
1 Year2%
3 Years6%
5 Years5%
TTM12%
EBITDA CAGR
1 Year11%
3 Years18%
5 Years17%
TTM17%
PAT CAGR
1 Year12%
3 Years19%
5 Years29%
TTM20%
Avg. ROCE
1 Year61%
3 Years57%
5 Years50%
TTM83%
CFO / EBITDA
1 Year69%
3 Years82%
5 Years82%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
858585169169169169169169169169169
Reserves
ReservesCr
2,0991,9221,9731,9701,6511,3092,4941,5721,6081,7822,0981,712
Current Liabilities
Current LiabilitiesCr
5797201,6001,4541,0241,3551,6981,3261,5251,9051,7791,806
Non Current Liabilities
Non Current LiabilitiesCr
292277290317291282272259254252277282
Total Liabilities
Total LiabilitiesCr
3,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,3243,969
Current Assets
Current AssetsCr
2,1741,6742,1862,0091,7752,2033,7082,4942,7983,4103,6063,230
Non Current Assets
Non Current AssetsCr
8811,3301,7611,9021,361912925832758698718738
Total Assets
Total AssetsCr
3,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,3243,969
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
858585169169169169169169169169169
Reserves
ReservesCr
2,0991,9221,9731,9701,6511,3092,4941,5721,6081,7822,0981,712
Current Liabilities
Current LiabilitiesCr
5797201,6001,4541,0241,3551,6981,3261,5251,9051,7791,806
Non Current Liabilities
Non Current LiabilitiesCr
292277290317291282272259254252277282
Total Liabilities
Total LiabilitiesCr
3,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,3243,969
Current Assets
Current AssetsCr
2,1741,6742,1862,0091,7752,2033,7082,4942,7983,4103,6063,230
Non Current Assets
Non Current AssetsCr
8811,3301,7611,9021,361912925832758698718738
Total Assets
Total AssetsCr
3,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,3243,969

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1392344733994915788114845821,290903
Investing Cash Flow
Investing Cash FlowCr
499301-104-143-57418-4068089-46397
Financing Cash Flow
Financing Cash FlowCr
-638-511-307-358-428-696-524-1,543-562-769-737
Net Cash Flow
Net Cash FlowCr
02462-1026300-119-25129475563
Free Cash Flow
Free Cash FlowCr
-69-246391563365368104515731,273870
CFO To PAT
CFO To PAT%
36.969.6134.889.7526.3201.2212.979.798.7139.187.2
CFO To EBITDA
CFO To EBITDA%
29.055.993.566.574.696.6106.460.264.0109.669.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1392344733994915788114845821,290903
Investing Cash Flow
Investing Cash FlowCr
499301-104-143-57418-4068089-46397
Financing Cash Flow
Financing Cash FlowCr
-638-511-307-358-428-696-524-1,543-562-769-737
Net Cash Flow
Net Cash FlowCr
02462-1026300-119-25129475563
Free Cash Flow
Free Cash FlowCr
-69-246391563365368104515731,273870
CFO To PAT
CFO To PAT%
36.969.6134.889.7526.3201.2212.979.798.7139.187.2
CFO To EBITDA
CFO To EBITDA%
29.055.993.566.574.696.6106.460.264.0109.669.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,19223,16717,66322,02021,09524,40128,17122,43232,91748,74338,68246,207
Price To Earnings
Price To Earnings
120.068.850.449.4226.468.116.636.755.852.537.340.9
Price To Sales
Price To Sales
11.38.06.27.06.58.38.66.99.513.010.111.1
Price To Book
Price To Book
14.811.58.610.311.616.510.612.918.525.017.124.6
EV To EBITDA
EV To EBITDA
64.453.132.434.730.438.933.726.535.140.228.532.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
48.247.352.052.055.052.454.156.557.259.061.261.2
OPM
OPM%
16.914.417.619.220.420.423.224.726.331.434.334.1
NPM
NPM%
13.311.612.214.22.99.811.618.717.124.727.127.6
ROCE
ROCE%
26.525.526.331.917.130.229.147.745.564.361.282.8
ROE
ROE%
17.216.817.120.85.119.414.334.933.247.545.761.0
ROA
ROA%
12.311.28.911.43.09.28.218.316.622.624.028.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,19223,16717,66322,02021,09524,40128,17122,43232,91748,74338,68246,207
Price To Earnings
Price To Earnings
120.068.850.449.4226.468.116.636.755.852.537.340.9
Price To Sales
Price To Sales
11.38.06.27.06.58.38.66.99.513.010.111.1
Price To Book
Price To Book
14.811.58.610.311.616.510.612.918.525.017.124.6
EV To EBITDA
EV To EBITDA
64.453.132.434.730.438.933.726.535.140.228.532.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
48.247.352.052.055.052.454.156.557.259.061.261.2
OPM
OPM%
16.914.417.619.220.420.423.224.726.331.434.334.1
NPM
NPM%
13.311.612.214.22.99.811.618.717.124.727.127.6
ROCE
ROCE%
26.525.526.331.917.130.229.147.745.564.361.282.8
ROE
ROE%
17.216.817.120.85.119.414.334.933.247.545.761.0
ROA
ROA%
12.311.28.911.43.09.28.218.316.622.624.028.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews